Circulating thrombomodulin during radiation therapy of lung cancer

Radiation Oncology Investigations

Volumn 7, Issue 4, 1999, Pages 238-242

  Hauer Jensen, Martin ^a,c   Kong, Feng Ming ^b   Fink, Louis M ^a   Anscher, Mitchell S ^b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b DUKE CANCER INSTITUTE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Lung cancer; Radiation injuries; Radiation pneumonitis; Thrombomodulin

Indexed keywords

THROMBOMODULIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; LUNG CANCER; LUNG TOXICITY; PRIORITY JOURNAL; RADIATION INJURY; RADIATION PNEUMONIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS; BIOLOGICAL MARKERS; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; THROMBOMODULIN;

EID: 0032886591     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1999)7:4<238::AID-ROI5>3.0.CO;2-4     Document Type: Article

References (28)

1. Wang J, Yao A, Wang J-Y, Sung C-C, Fink LM, Hardin JW, Hauer-Jensen M. cDNA cloning and sequencing, gene expression, and immunolocalization of thrombomodulin in the Sprague-Dawley rat. DNA Res 1999;6:57-62.
2. Zhou Q, Zhao Y, Xu C, Yu Z, Yao D, Gao Y, Ruan C. Increase in plasma thrombomodulin and decrease in plasma von Willebrand factor after regular radiotherapy of patients with cancer. Thromb Res 1992;68:109-118.
3. Anscher MS, Kong FM, Andrews K, Clough R, Marks LB, Bentel G, Jirtle RL. Plasma transforming growth factor β1 as predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 1998;41:1029-1035.
4. Marks LB, Spencer DP, Bentel GC, Ray SK, Sherouse GW, Sontag MR, Coleman RE, Jaszczak RJ, Turkington TG, Tapson V, Prosnitz LR. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int J Radiat Oncol Biol Phys 1993;26:659-668.
5. Zhou Q, Zhao Y, Li P, Bai X, Ruan C. Thrombomodulin as a marker of radiation-induced endothelial cell injury. Radiat Res 1992;131:285-289.
6. Richter KK, Fink LM, Hughes BM, Sung C-C, Hauer-Jensen M. Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy? Radiother Oncol 1997;44:65-71.
7. Richter KK, Fink LM, Hughes BM, Shmaysani HM, Sung C-C, Hauer-Jensen M. Differential effect of radiation on endothelial cell function in rectal cancer and normal rectum. Am J Surg 1998;176:642-647.
8. Wang J, Richter KK, Sung C-C, Hauer-Jensen M: Association of chronic endothelial dysfunction with sustained transforming growth factor-β (TGF-β) overexpression and progression of experimental radiation enteropathy. Radiat Res Soc 1997;45:194.
9. Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987;79:124-130.
10. Nawroth PP, Handley DA, Esmon CT, Stern DM. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA 1986;83:3460-3464.
11. Lentz SR, Tsiang M, Sadler JE. Regulation of thrombomodulin by tumor necrosis factor-7α comparison of transcriptional and posttranscriptional mechanisms. Blood 1991;77:542-550.
12. Ohji T, Urano H, Shirahata A, Yamagishi M, Higashi K, Gotoh S, Karasaki Y. Transforming growth factor β1 and β2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb Haemost 1995;73:812-818.
13. Abe H, Okajima K, Okabe H, Takatsuki K, Binder BR. Granulocyte proteases and hydrogen peroxide synergistically inactivate thrombomodulin of endothelial cells in vitro. J Lab Clin Med 1994;123:874-881.
14. Glaser CB, Morser J, Clarke JH, Blasko E, McLean K, Kuhn I, Chang RJ, Lin JH, Vilander L, Andrews WH, Light DR. Oxidation of a specific methionin in thrombomodulin by activated neutrophil products blocks cofactor activity. J Clin Invest 1992;90:2565-2573.
15. Teasdale MS, Bird CH, Bird P. Internalization of the anticoagulant thrombomodulin is constitutive and does not require a signal in the cytoplasmic domain. Immunol Cell Biol 1994;72:480-488.
16. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991;65: 618-623.
17. Boehme MWJ, Deng Y, Raeth U, Bierhaus A, Ziegler R, Stremmel W, Nawroth PP. Release of thrombomodulin from endothelial cells by concerted action of TNF-α and neutrophils: in vivo and in vitro studies. Immunology 1996;87:134-140.
18. Ohdama S, Takano S, Miyake S, Kubota T, Sato K, Aoki N. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. Am J Clin Pathol 1994;101:109-113.
19. Blann AD, Daly RJ, Amiral J. The influence of age, gender and ABO blood group on soluble endothelial cell markers and adhesion molecules. Br J Haematol 1996;92:498-500.
20. Markuljak I, Ivankova J, Kubisz P. Thrombomodulin and von Willebrand factor in smokers and during smoking. Nouv Rev Fr Hematol 1995;37:137-139.
21. Marckmann P, Nawroth P, Wahl P, Jespersen J. Diet, gender, and plasma thrombomodulin. Thromb Res 1996;82:439-443.
22. Iba T, Yagi Y, Kidokoro A, Fukunaga M, Fukunaga T. Increased plasma levels of soluble thrombomodulin in patients with sepsis and organ failure. Surg Today 1995;25:585-590.
23. Boldt I, Wollbrück T, Sonnebom S, Welters A, Hempelmann G. Thrombomodulin in intensive care patients. Intensive Care Med 1995;21:645-650.
24. Endo S, Inada K, Nakae H, Takakuwa T, Kasai T, Yamada Y, Suzuki T, Taniguchi S, Yoshida M. Blood levels of endothelin-I and thrombomodulin in patients with disseminated intravascular coagulation and sepsis. Res Commun Mol Pathol Pharmacol 1995;90:277-288.
25. Hergesell O, Andrassy K, Nawroth P. Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thromb Haemost 1996;75:892-898.
26. Sawyerr AM, Smith MS, Hall A, Hudson M, Hay CR, Wakefield AJ, Brook MG, Tomura H, Pounder RE. Serum concentration of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases. Dig Dis Sci 1995;40:793-799.
27. Boehme MWJ, Autschbach F, Zuna I, Scherbaum WA, Stange E, Raeth U, Sieg A, Stremmel W. Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis. Gastroenterology 1997;113:107-117.
28. Healy AM, Hancock WW, Christie PD, Rayburn HB, Rosenberg RD. Intravascular coagulation activation in a murine model of thrombomodulin deficiency: effects of lesion size, age, and hypoxia on fibrin desposition. Blood 1998;92:4188-4197.